Picture of RxSight logo

RXST — RxSight News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Rxsight Inc reports results for the quarter ended in September - Earnings Summary

* Rxsight Inc  RXST.OQ  reported a quarterly adjusted loss
of 61
cents​​ per share for the quarter ended in September. The mean
expectation of five analysts for the quarter was for a loss
of 71 cents per share.
    * Revenue rose 118% to $12.62 million from a year ago;
analysts
expected $10.98 million. 
    * Rxsight Inc's reported EPS for the quarter was a loss
of 61
cents​.
    * The mean earnings estimate of analysts had risen by
about 1.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Rxsight Inc shares had fallen by 2.5% this quarter and
gained 4.0% so far this year.
    * The company reported a quarterly loss of $16.82 million.
    * Wall Street's median 12-month price target for Rxsight Inc
is
$22.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 04:02 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.71          -0.61          Beat
 Jun. 30 2022      -0.69          -0.61          Beat
 Mar. 31 2022      -0.65          -0.64          Beat
 Dec. 31 2021      -0.68          -0.58          Beat

Recent news on RxSight

See all news